Back to Search
Start Over
Proposed Multicenter Studies
- Source :
- Journal of Burn Care & Research. 30:188-189
- Publication Year :
- 2009
- Publisher :
- Oxford University Press (OUP), 2009.
-
Abstract
- A second potential therapeutic option for the parenchymal damage caused by inhalation injury is systemic administration of intravenous agents. The unique nature of the effects of the burn and smoke on lung physiology and immunology create new opportunities for systemic treatments targeting specific aspects of the response to injury. In addition, systemic therapies could be either isolated or combined with inhalation therapies to achieve optimal clinical response. The two articles in this section of the compendium address different, yet promising, systemic therapies: antithrombin and vitamin C.
- Subjects :
- medicine.medical_specialty
Serine Proteinase Inhibitors
Smoke Inhalation Injury
Antithrombin III
Inflammation
Ascorbic Acid
Respiratory physiology
Antioxidants
medicine
Animals
Humans
Multicenter Studies as Topic
Intensive care medicine
Randomized Controlled Trials as Topic
Sheep
Inhalation
business.industry
Rehabilitation
Antithrombin
Ascorbic acid
Clinical trial
Research Design
Immunology
Emergency Medicine
Systemic administration
Surgery
medicine.symptom
business
medicine.drug
Subjects
Details
- ISSN :
- 1559047X
- Volume :
- 30
- Database :
- OpenAIRE
- Journal :
- Journal of Burn Care & Research
- Accession number :
- edsair.doi.dedup.....642306624f3545aec6fc8c0359cfa567